136 related articles for article (PubMed ID: 38360802)
1. LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless Story.
Minotti G; Camilli M
J Pharmacol Exp Ther; 2024 Feb; 388(3):739-741. PubMed ID: 38360802
[No Abstract] [Full Text] [Related]
2. Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.
Sniderman AD; Thanassoulis G
Evid Based Med; 2013 Apr; 18(2):73-4. PubMed ID: 22893654
[No Abstract] [Full Text] [Related]
3. Lipid parameters and cardiovascular events in patients taking statins.
Brook RD; Rubenfire M
JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403
[No Abstract] [Full Text] [Related]
4. Lipid parameters and cardiovascular events in patients taking statins.
Martin SS; Jones SR
JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402
[No Abstract] [Full Text] [Related]
5. Systematic review and meta-regression on the duration of LDL-C lowering and major adverse cardiovascular events.
Redel-Traub G; Smilowitz NR; Xia Y; Berger JS
Vasc Med; 2022 Aug; 27(4):375-376. PubMed ID: 35603756
[No Abstract] [Full Text] [Related]
6. Review: More-intensive vs less-intensive LDL-cholesterol lowering reduces mortality.
Yeboah J
Ann Intern Med; 2018 Jul; 169(2):JC6. PubMed ID: 30014095
[No Abstract] [Full Text] [Related]
7. [How far the rates of cholesterol have to be lowered in primary prevention?].
Rodondi N
Rev Med Suisse; 2010 Mar; 6(239):483-4. PubMed ID: 20373693
[No Abstract] [Full Text] [Related]
8. [Elderly benefit from lower LDL-cholesterol].
Wiklund O
Lakartidningen; 2021 Mar; 118():. PubMed ID: 33768516
[TBL] [Abstract][Full Text] [Related]
9. Reductions in LDL-cholesterol and blood-pressure levels have cumulative benefits.
Lim GB
Nat Rev Cardiol; 2019 Nov; 16(11):650. PubMed ID: 31530886
[No Abstract] [Full Text] [Related]
10. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
Olsson AG
Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
[No Abstract] [Full Text] [Related]
11. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ
JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571
[TBL] [Abstract][Full Text] [Related]
12. PCSK9 Inhibitors and Cardiovascular Events.
Sabatine MS; Wasserman SM; Stein EA
N Engl J Med; 2015 Aug; 373(8):774-5. PubMed ID: 26295078
[No Abstract] [Full Text] [Related]
13. PCSK9 Inhibitors and Cardiovascular Events.
Goemann IM; Londero TM; Dora JM
N Engl J Med; 2015 Aug; 373(8):773-4. PubMed ID: 26287856
[No Abstract] [Full Text] [Related]
14. PCSK9 Inhibitors and Cardiovascular Events.
Auer J; Berent R; Primus C
N Engl J Med; 2015 Aug; 373(8):773. PubMed ID: 26287855
[No Abstract] [Full Text] [Related]
15. PCSK9 Inhibitors and Cardiovascular Events.
Robinson JG; Kastelein JJ
N Engl J Med; 2015 Aug; 373(8):774. PubMed ID: 26287854
[No Abstract] [Full Text] [Related]
16. Further LDL Lowering Could Reduce Cardiovascular Risk.
Mechcatie E; Rosenberg K
Am J Nurs; 2018 Nov; 118(11):55-56. PubMed ID: 30358599
[TBL] [Abstract][Full Text] [Related]
17. Is intensive LDL-cholesterol lowering beneficial and safe?
Cheung BM; Lam KS
Lancet; 2010 Nov; 376(9753):1622-4. PubMed ID: 21067806
[No Abstract] [Full Text] [Related]
18. Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups.
Lee J; Holbrook A
Ann Intern Med; 2019 Jun; 170(12):JC65. PubMed ID: 31207618
[No Abstract] [Full Text] [Related]
19. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?
Cesena FHY; Laurinavicius AG; Valente VA; Conceição RD; Santos RD; Bittencourt MS
Clin Cardiol; 2018 Mar; 41(3):333-338. PubMed ID: 29574925
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
Mitka M
JAMA; 2010 Jan; 303(3):211-2. PubMed ID: 20085945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
